Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Optimizing Antimicrobial Stewardship (AMS) Interventions and Outcomes in Clinical Outcomes, Optimal Use and Resource Utilizatio
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Antimicrobial Stewardship —Treatment optimization under antibiotics appropriate use policy in China
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Research on Exploring Disease Assessment and Prioritizing Systematic Treatment for Vitiligo
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Quality Improvement in Molecular Testing Pathways for Metastatic Colorectal Cancer (mCRC)
    Release Date:
    Partner: American Society for Clinical Pathology (ASCP)
    Review Process: Expert Review Panel
    Quality Improvement Oncology USA
    Personalized monitoring&treatment for HR+, HER2- mBC patients treated w CDK4/6i: incorporating Patient complexity risk factors
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement, Research Oncology Italy
    Providing Appropriate Medical Care for IBD Patients
    Release Date:
    Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Inflammation & Immunology Japan
    Administration of brentuximab vedotin alone or in combination with other approved agents in pre and/or peri CAR-T
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology USA
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Programs Toward Improving the Quality of Depression Treatment
    Release Date:
    Improving Patient Care in Inflammatory Bowel Disease (IBD) through Shared Decision-Making
    Release Date:
    Review Process:
    Developing Clinical Research and Publication Skills - AfME and EU
    Release Date:
    Review Process:
    Developing Clinical Research and Publication Skills – UK
    Release Date:
    Review Process:
    Inflammatory Bowel Disease Fellowships
    Release Date:
    Improving Health Outcomes in Atopic Dermatitis (AD) through Shared Decision-Making
    Release Date:
    Review Process:
    Patient Decision Aids for Inflammatory Conditions
    Release Date:
    Review Process:
    Improving Assessment and Treatment of Acute Vaso-occlusive Crisis
    Release Date:
    Rheumatology Fellowship
    Release Date:
    Review Process:
    Developing Clinical Research and Publication Skills – UK (Re-release)
    Release Date:
    Review Process:
    Developing Clinical Research and Publication Skills - AfME and EU (Re-release)
    Release Date:
    Review Process:
    Dermatology Fellowship
    Release Date:
    Review Process: